rosiglitazone has been researched along with latrunculin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumberg, N; Francis, CW; Murant, TI; O'Brien, JJ; Phipps, RP; Pollock, SJ; Ray, DM; Spinelli, SL; Taubman, MB | 1 |
1 other study(ies) available for rosiglitazone and latrunculin a
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.
Topics: Adult; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Collagen; Dimerization; DNA; Female; Humans; Male; Megakaryocytes; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; PPAR gamma; Protein Binding; Protein Isoforms; Retinoid X Receptor alpha; Retinoid X Receptor beta; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thiazolidines; Thrombin; Time Factors; Transport Vesicles | 2008 |